tesamorelin and retatrutide together Tonight’s peptide stack 🤍, is honestly blowing traditional GLP-1s out of the water — here’s why: it targets multiple metabolic pathways, not just one. By acting on GLP-1 plus Tesamorelin and Retatrutide Together: Safety,

Link Jastreboff et al., NEJM 2023 (Phase 2 obesity)

It is also unclear whether patients would have to take these drugs for the rest of their lives or in combination with other procedures and therapies

The 12mg dose pushed to 24.2%, exceeding anything previously documented in pharmaceutical weight loss trials

Read more February 19, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on

However, efpeglenatide was also effective as a biweekly and once-monthly subcutaneous injection, illustrating the opportunity to produce ever longer-acting GLP-1RAs for less frequent administration [39]